WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000063405) VECTORS CONTAINING A GENE CODING FOR CD40 AND/OR CD40L UNDER THE CONTROL OF A CYTOKINE-INDUCIBLE PROMOTER, METHODS FOR THEIR PRODUCTION AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/063405    International Application No.:    PCT/EP2000/003353
Publication Date: 26.10.2000 International Filing Date: 13.04.2000
Chapter 2 Demand Filed:    15.09.2000    
IPC:
A61K 38/00 (2006.01), A61K 48/00 (2006.01), C07K 14/705 (2006.01)
Applicants: F. HOFFMANN-LA ROCHE AG [CH/CH]; CH-4070 Basle (CH) (For All Designated States Except US).
FRIESS, Thomas [DE/DE]; (DE) (For US Only).
MAASS, Gerd [DE/DE]; (DE) (For US Only).
PESSARA, Ulrich [DE/DE]; (DE) (For US Only).
SCHEUER, Werner [DE/DE]; (DE) (For US Only).
SEEBER, Stefan [DE/DE]; (DE) (For US Only)
Inventors: FRIESS, Thomas; (DE).
MAASS, Gerd; (DE).
PESSARA, Ulrich; (DE).
SCHEUER, Werner; (DE).
SEEBER, Stefan; (DE)
Agent: SCHREINER, Siegfried; Roche Diagnostics GmbH, Patent Department Pharma (TR-E), P.O. Box 11 52, D-82372 Penzberg (DE)
Priority Data:
99107611.8 16.04.1999 EP
Title (EN) VECTORS CONTAINING A GENE CODING FOR CD40 AND/OR CD40L UNDER THE CONTROL OF A CYTOKINE-INDUCIBLE PROMOTER, METHODS FOR THEIR PRODUCTION AND USES THEREOF
(FR) VECTEURS CONTENANT UN GENE CODANT POUR CD40 ET/OU CD40L, SOUS LA COMMANDE D'UN PROMOTEUR POUVANT ETRE INDUIT PAR UNE CYTOKINE, ET PROCEDES DE PRODUCTION ET UTILISATIONS DE CES VECTEURS
Abstract: front page image
(EN)A vector for the expression of a nucleic acid encoding at least one polypeptide with CD40 and/or CD154 activity, wherein the expression of said nucleic acid is under the control of a cytokine-inducible promoter, is preferably administered locally to solid tumors for tumor therapy.
(FR)L'invention concerne un vecteur destiné à l'expression d'un acide nucléique codant au moins pour un polypeptide possédant une activité de CD40 et/ou de CD154, l'expression de cet acide nucléique étant commandée par un promoteur pouvant être induit par une cytokine. De préférence, on administre ce vecteur localement sur des tumeurs solides, aux fins de thérapie de celles-ci.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)